Previous Section
Drug Therapy
11. The effects of imatinib on pregnancy outcome.
- Author
- Pye SM; Cortes J; Ault P; Hatfield A; Kantarjian H; Pilot R; Rosti G; Apperley JF;
- Institution
- Department of Haematology, Division of Investigative Science, Imperial College, London, United Kingdom. s.pye@imperial.ac.uk
- Journal
- Blood. 2008 Jun 15;111(12):5505-8. Epub 2008 Mar 5.
- Abstract URL
- Click here to view abstract
12. Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.
- Author
- Hochhaus A; Baccarani M; Deininger M; Apperley JF; Lipton JH; Goldberg SL; Corm S; Shah NP; Cervantes F; Silver RT; Niederwieser D; Stone RM; Dombret H; Larson RA; Roy L; Hughes T; Muller MC; Ezzeddine R; Countouriotis AM; Kantarjian HM;
- Institution
- III Medizinische Klinik, Medizinische Fakultat Mannheim, Universitat Heidelberg, Mannheim, Germany. hochhaus@uni-hd.de
- Journal
- Leukemia. 2008 Jun;22(6):1200-6. Epub 2008 Apr 10.
- Abstract URL
- Click here to view abstract
13. Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials.
- Author
- Roy L; Guilhot J; Krahnke T; Guerci-Bresler A; Druker BJ; Larson RA; O'Brien S; So C; Massimini G; Guilhot F;
- Institution
- Department of Oncology-Hematology and Cell Therapy, EA 3805, CHU La Miletrie, 2 Rue de la Miletrie, 86021 POITIERS CEDEX, France.
- Journal
- Blood. 2006 Sep 1;108(5):1478-84. Epub 2006 Apr 20.
- Abstract URL
- Click here to view abstract
14. Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate.
- Author
- Jabbour E; Kantarjian H; Jones D; Talpaz M; Bekele N; O'Brien S; Zhou X; Luthra R; Garcia-Manero G; Giles F; Rios MB; Verstovsek S; Cortes J;
- Institution
- Department of Leukemia, The University of Texas, UT MD Anderson Cancer Center, Houston, TX 77030, USA.
- Journal
- Leukemia. 2006 Oct;20(10):1767-73. Epub 2006 Jul 20.
- Abstract URL
- Click here to view abstract
15. Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib.
- Author
- Breccia, M; Carmosino, I; Russo, E; Morano, S G; Latagliata, R; Alimena, G;
- Institution
- Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy. breccia@bce.uniroma1.it
- Journal
- Eur J Haematol 2005 Feb;74(2):121-3.
- Abstract URL
- Click here to view abstract
16. Imatinib (Gleevec)-induced hepatotoxicity.
- Author
- Ayoub, Walid S; Geller, Stephen A; Tran, Tram; Martin, Paul; Vierling, John M; Poordad, F Fred;
- Institution
- Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
- Journal
- J Clin Gastroenterol 2005 Jan;39(1):75-7.
- Abstract URL
- Click here to view abstract
Next: Clinical Trials
